Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Torrent Pharmaceuticals has informed that The USFDA inspected its manufacturing facility at Vizag, Andhra Pradesh from 28-July-25 to 01-August-25. The Inspection has been concluded with Zero observation.
The above information is a part of company’s filings submitted to BSE.